(Q46773983)

English

Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/24720708

Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational study (English)

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/24720708

1 reference

based on heuristic

inferred from title

circulatory system

1 reference

based on heuristic

inferred from title

Sara Jenkins-Jones

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24720708%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

C Ll Morgan

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24720708%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

J Mukherjee

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24720708%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

S E Holden

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24720708%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

C J Currie

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24720708%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

8 May 2014

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/24720708

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24720708%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24720708%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24720708%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

957-962

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24720708%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12302

21 January 2018

Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12302

21 January 2018

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12302

21 January 2018

Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12302

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12302

21 January 2018

Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12302

21 January 2018

Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12302

21 January 2018

Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12302

21 January 2018

Sulphonylureas and risk of cardiovascular disease: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12302

21 January 2018

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12302

21 January 2018

Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12302

21 January 2018

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12302

21 January 2018

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12302

21 January 2018

Use of metformin in the setting of mild-to-moderate renal insufficiency

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12302

21 January 2018

Contraindications to metformin therapy in patients with Type 2 diabetes--a population-based study of adherence to prescribing guidelines

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12302

21 January 2018

Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12302

21 January 2018

Severe hypoglycemia and risks of vascular events and death

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12302

21 January 2018

Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12302

21 January 2018

Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12302

21 January 2018

Metformin: An Update

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12302

21 January 2018

Metformin use and mortality among patients with diabetes and atherothrombosis

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12302

21 January 2018

Identifiers

10.1111/DOM.12302

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24720708%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24720708%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46773983&oldid=2130953469"